1. Senescence & Senolytic Research
Fisetin is studied as a flavonoid senolytic candidate. Preclinical work indicates intermittent treatment can reduce senescence markers and SASP-related signaling in aged or progeroid models.
Citation: Yousefzadeh et al., EBioMedicine (2018): fisetin as a senotherapeutic that extends health and lifespan in mice.View source









